Inventor
MCKEARN JOHN
US16 patents
⚠️ This page may combine multiple inventors who share the name “MCKEARN JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PATHOLOGICA LLC
6 patentsUS9675566B2Jun 13, 2017
Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing
PATHOLOGICA LLC5 citations82
US9668988B2Jun 6, 2017
Controlled release oral pharmaceutical dosage forms comprising MGBG
PATHOLOGICA LLC4 citations82
US10881626B2Jan 5, 2021
Controlled release oral pharmaceutical dosage forms comprising MGBG
PATHOLOGICA LLC1 citations71
US10292950B2May 21, 2019
Method of treatment with anti-inflammatory and analgesic compounds which are GI-, renal-, and platelet-sparing
PATHOLOGICA LLC3 citations71
US10350178B2Jul 16, 2019
Methods and compositions for treatment of demyelinating diseases
PATHOLOGICA LLC1 citations61
US10085955B2Oct 2, 2018
Methods and compositions for treatment of demyelinating diseases
PATHOLOGICA LLC1 citations51
MCKEARN JOHN
4 patentsUS8609734B2Dec 17, 2013
Methods of treating pain with MGBG
MCKEARN JOHN14 citations91
US8258186B2Sep 4, 2012
Pharmaceutical for oral delivery comprising MGBG
MCKEARN JOHN20 citations91
US8858991B2Oct 14, 2014
Delayed release oral pharmaceutical dosage forms comprising MGBG
MCKEARN JOHN11 citations82
US9616035B2Apr 11, 2017
Pharmaceutical for oral delivery comprising MGBG and methods of treating disease
MCKEARN JOHN1 citations61
BIOENERGENIX LLC
4 patentsUS9193693B2Nov 24, 2015
Heterocyclic compounds for the inhibition of PASK
BIOENERGENIX LLC4 citations83
US10781185B2Sep 22, 2020
Heterocyclic compounds for the inhibition of PASK
BIOENERGENIX LLC1 citations72
US9868708B2Jan 16, 2018
Heterocyclic compounds for the inhibition of PASK
BIOENERGENIX LLC3 citations72
US11459307B2Oct 4, 2022
Heterocyclic compounds for the inhibition of PASK
BIOENERGENIX LLC0 citations62